Literature DB >> 17330094

High-throughput, sensitive and quantitative assay for the detection of BCR-ABL kinase domain mutations.

A Vivante, N Amariglio, M Koren-Michowitz, O Ashur-Fabian, A Nagler, G Rechavi, Y Cohen.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17330094     DOI： 10.1038/sj.leu.2404635

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  12 in total

1.  High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN).

Authors:  Nir Lubezky; Menahem Ben-Haim; Sylvia Marmor; Eli Brazowsky; Gideon Rechavi; Joseph M Klausner; Yoram Cohen
Journal:  J Gastrointest Surg       Date:  2011-01-12       Impact factor: 3.452

2.  MassARRAY, pyrosequencing, and PNA clamping for EGFR mutation detection in lung cancer tissue and cytological samples: a multicenter study.

Authors:  Kyueng-Whan Min; Wan-Seop Kim; Se Jin Jang; Yoo Duk Choi; Sunhee Chang; Soon Hee Jung; Lucia Kim; Mee-Sook Roh; Choong Sik Lee; Jung Weon Shim; Mi Jin Kim; Geon Kook Lee
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-17       Impact factor: 4.553

3.  A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes.

Authors:  Debora Fumagalli; Patrick G Gavin; Yusuke Taniyama; Seung-Il Kim; Hyun-Joo Choi; Soonmyung Paik; Katherine L Pogue-Geile
Journal:  BMC Cancer       Date:  2010-03-16       Impact factor: 4.430

4.  Mutation analysis of the ferritin L-chain gene in age-related cataract.

Authors:  Nurit Assia; Nitza Goldenberg-Cohen; Gideon Rechavi; Ninette Amariglio; Yoram Cohen
Journal:  Mol Vis       Date:  2010-11-24       Impact factor: 2.367

5.  Laboratory practice guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic leukemia: a report of the Association for Molecular Pathology.

Authors:  Dan Jones; Suzanne Kamel-Reid; David Bahler; Henry Dong; Kojo Elenitoba-Johnson; Richard Press; Neil Quigley; Paul Rothberg; Dan Sabath; David Viswanatha; Karen Weck; James Zehnder
Journal:  J Mol Diagn       Date:  2008-12-18       Impact factor: 5.568

6.  Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

Authors:  Julio C Ricarte-Filho; Mabel Ryder; Dhananjay A Chitale; Michael Rivera; Adriana Heguy; Marc Ladanyi; Manickam Janakiraman; David Solit; Jeffrey A Knauf; R Michael Tuttle; Ronald A Ghossein; James A Fagin
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

7.  Comprehensive molecular oncogenomic profiling and miRNA analysis of prostate cancer.

Authors:  Seema Sethi; Dejuan Kong; Sue Land; Gregory Dyson; Wael A Sakr; Fazlul H Sarkar
Journal:  Am J Transl Res       Date:  2013-03-28       Impact factor: 4.060

8.  A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib.

Authors:  Thomas Ernst; Franz X Gruber; Oliver Pelz-Ackermann; Jacqueline Maier; Markus Pfirrmann; Martin C Müller; Ingvild Mikkola; Kimmo Porkka; Dietger Niederwieser; Andreas Hochhaus; Thoralf Lange
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

9.  A single-tube allele specific-polymerase chain reaction to detect T315I resistant mutation in chronic myeloid leukemia patients.

Authors:  Wanwisa Wongboonma; Wanna Thongnoppakhun; Chirayu U Auewarakul
Journal:  J Hematol Oncol       Date:  2011-02-08       Impact factor: 17.388

10.  Rapid identification of compound mutations in patients with Philadelphia-positive leukaemias by long-range next generation sequencing.

Authors:  R Kastner; A Zopf; S Preuner; J Pröll; N Niklas; P Foskett; P Valent; T Lion; C Gabriel
Journal:  Eur J Cancer       Date:  2013-12-20       Impact factor: 9.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.